[EN] SELECTIVE HISTONE DEACETYLASE 6 INHIBITORS<br/>[FR] INHIBITEURS SÉLECTIFS DE L'HISTONE DÉSACÉTYLASE 6
申请人:THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOS
公开号:WO2021263171A1
公开(公告)日:2021-12-30
The present disclosure provides methods, pharmaceutical compositions, and kits comprising histone deacetylase (HD AC) inhibitors of formula I, or a pharmaceutically acceptable salt thereof, wherein R1, R2, L1, L2, m, n, p, X, Y, and Z are as defined in the specification, including methods of increasing the sensitivity of cancer cells to the cytotoxic effects of radiotherapy and/or chemotherapy in a subject.
本公开提供了一种方法、制药组合物和工具包,其中包括式I的组蛋白去乙酰化酶(HDAC)抑制剂或其药学上可接受的盐,其中R1、R2、L1、L2、m、n、p、X、Y和Z如规范中所定义,包括增加癌细胞对放疗和/或化疗的细胞毒性作用的敏感性方法。